The eighth in Health Rising’s recent recovery story series brings yet another slant on recovery. We’ve had fast recoveries where someone found “the thing” (Melissa’s spinal patch, Rachel and Adam’s vaccines) that quickly turned...
The first blog in a couple of weeks is different – it’s not on ME/CFS/FM or long COVID per se – and that may be a good note to start out on. It’s a reminder that ME/CFS is not alone – that it shares broad themes with other diseases – some...
If any treatment has promise, vagus nerve stimulation (VNS) does. Through its stimulation of the rest/digest system (the parasympathetic nervous system (PNS)), VNS has the potential to tamp down the fight/flight system that seems to be raging in chronic fatigue...
The big news in David Systrom’s “Neurovascular Dysregulation Underlies Exercise Intolerance in ME/CFS” talk at the CDC yesterday was that the $8 million mitochondrial drug trial had, unfortunately, failed. The ME/CFS Mitochondrial Drug Trial Fails...
The Ramsay Awards provide pilot grants that give researchers the ability to gather the data they need to apply for much larger NIH grants. As it has over the past couple of years, the Solve ME Initiative places a heavy focus on funding clinical trials that could...
Step by step Lipkin’s metabolomic study produces a coherent picture of mitochondrial dysfunction The really neat thing about Ian Lipkin’s latest work on ME/CFS is how well all the results fit together. Health Rising reported on the preprint of this...
